Related Experiment Video
Updated: Aug 26, 2025

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
Published on: June 5, 2017
How effective are ionization state-based QSPKR models at predicting pharmacokinetic parameters in humans?
Anish Gomatam1, Blessy Joseph1, Poonam Advani2
1Department of Pharmaceutical Chemistry, Bombay College of Pharmacy, Mumbai, India.
Predicting drug pharmacokinetics (PK) using in silico models is challenging. This study found that grouping drug candidates by ionization state did not improve quantitative structure-PK relationship (QSPKR) models for predicting PK parameters like clearance and half-life.
Area of Science:
- Pharmacology
- Computational Chemistry
- Drug Development
Background:
- Optimizing drug pharmacokinetics (PK) for oral dosing is crucial but challenging.
- Traditional PK estimation methods are time-consuming and expensive.
- Quantitative structure-pharmacokinetic relationship (QSPKR) models offer an in silico alternative.
Purpose of the Study:
- To develop predictive QSPKR models for human PK parameters using an ionization state-based strategy.
- To investigate the impact of molecular ionization state on PK modeling.
- To build models for plasma clearance (CL), steady-state volume of distribution (VDss), and half-life (t1/2).
Main Methods:
- Clustering a drug dataset based on ionization state at physiological pH.
- Developing global and ion subset-based QSPKR models using 'EigenValue ANalySis' and support vector machine.
- Accounting for stereospecificity in drug disposition.
Main Results:
- Categorizing compounds by ionization state did not improve QSPKR model performance.
- Narrow endpoint ranges and data redundancy negatively impacted ion subset-based models.
- The ionization state-based strategy was not superior to global modeling.
Conclusions:
- Ionization state-based QSPKR models are not effective for improving PK prediction.
- Alternative strategies like elimination route-based models for CL and chemotype-specific QSPKR for VDss are recommended.
- Further research should explore drug-transporter interactions and chemotype-specific modeling.
More Related Videos
07:23Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
Published on: October 20, 2023
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
Related Concept Videos
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
Model Approaches for Pharmacokinetic Data: Physiological Models
Physiological Pharmacokinetic Models: Incorporating Hepatic Transporter-Mediated Clearance
A recent model describes pravastatin's hepatobiliary excretion,...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...